With the recent passage of the SUPPORT for Patients and Communities Act and
In this archived webinar, the speakers will discuss typical treatment regiments for buprenorphine, describe barriers and solutions to pharmacist dispensing of MAT and highlight interactions between pharmacists and patients who use buprenorphine.
At the completion of this knowledge-based activity, participants will be able to:
- Discuss the typical treatment regimens for buprenorphine including induction steps, dosing, duration of therapy, and monitoring.
- Discuss the epidemiology of treatment gaps for opioid use disorder and the current and future roles of the pharmacist to address these gaps.
- Describe the barriers and solutions to pharmacist dispensing of MAT.
- Compare and contrast positive and negative interactions between pharmacists and patients who use buprenorphine.
Activity type: Knowledge-based
Target Audience: Pharmacists and Technicians
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-131-H01-P/T.
To obtain credit for completing Pharmacists’ Roles in Medication-Centered Addiction Treatment (MAT) (Home Study), watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: February 26, 2019
Expiration date: February 26, 2022
Pharmacists’ Roles in Medication-Centered Addiction Treatment (MAT) (Home Study) is an archived, online educational activity for pharmacists and pharmacist technicians developed by the American Pharmacists Association.
Jeffrey Bratberg, PharmD, Thomas Franko, PharmD, BCACP, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this member only activity.
The archived webinar (home-study version) will be available to APhA members ONLY, as a free member benefit.*
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-19-131-H01-P||0.1 CEUs||February 26, 2019 - February 26, 2022|
|ACPE# 0202-0000-19-131-H01-T||0.1 CEUs||February 26, 2019 - February 26, 2022|